Purchase Order 75N92E19P00109

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 27, 2013, with a ceiling value of $88,088.10 under cost-no-fee pricing.</p> <p>Place of performance is Bethesda, MD. The order has an ultimate completion date of August 31, 2015. The source does not specify the parent vehicle name or the specific deliverables under this order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $5,712.00 on August 18, 2017, with ultimate completion by September 15, 2017. Place of performance is Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. Specific deliverables or line items are not detailed in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 1, 2017, with a ceiling value of $5,273.81 under a firm fixed-price arrangement.</p> <p>Place of performance is North Bethesda, MD. The order has an ultimate completion date of September 1, 2017. No set-aside was used for this delivery order.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 30, 2017, with a ceiling value of $7,216.30 for genomic analysis equipment and services.</p> <p>Place of performance is North Bethesda, MD. The order is priced on a firm fixed-price basis and has an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $24,926.45 delivery order to Illumina, Inc. on September 19, 2019, under a firm fixed-price structure.</p> <p>Place of performance is Bethesda, MD. The order was due for completion on September 2, 2020. No set-aside was applied to this delivery order.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on March 27, 2018, with a ceiling value of $19,253.76 for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed price and was not issued under a set-aside. Ultimate completion date is September 2, 2020.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on November 28, 2017, with a ceiling value of $52,494.10 for genetic sequencing and genomic analysis technologies and services.</p> <p>Place of performance is Bethesda, MD 20892. The order was priced on a firm fixed-price basis with an ultimate completion date of September 2, 2020. No set-aside was used for this delivery order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>